Transcriptional regulation of 1-cys peroxiredoxin by the proto-oncogene protein DEK

Molecular Medicine Reports

Volumn 3, Issue 5, 2010, Pages 877-881

  Kim, Dong Wook ^b   Kim, J I Young ^a   Choi, Sulji ^a   Rhee, Sangmyung ^a   Hahn, Yoonsoo ^a   Seo, Sang Beom ^a  

^a Chung Ang University   (South Korea)

^b CHA University   (South Korea)

Author keywords

1 cys peroxiredoxin; DEK; P65; Transcription

Indexed keywords

1 CYS PEROXIREDOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PEROXIREDOXIN; PHOSPHOPROTEIN; PROTEIN DEK; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; HUMAN CELL;

EID: 78049494426     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.346     Document Type: Article

References (15)

1. Von Lindern M, Fornerod M, van Baal S, et al: The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 12: 1687-1697, 1992.
2. Ko SI, Lee IS, Kim JY, Kim SM, Kim DW, Lee KS, Woo KM, Baek JH, Choo JK and Seo SB: Regulation of histone acetyl-transferase activity of p300 and PCAF by proto-oncogene protein DEK. FEBS Lett 580: 3217-3222, 2006.
3. Waldmann T, Scholten I, Kappes F, Hu HG and Knippers R: The DEK protein - an abundant and ubiquitous constituent of mammalian chromatin. Gene 343: 1-9, 2004.
4. Kappes F, Scholten I, Richter N, Gruss C and Waldmann T: Functional domains of the ubiquitous chromatin protein DEK. Mol Cell Biol 24: 6000-6010, 2004. (Pubitemid 38787982)
5. Alexiadis V, Waldmann T, Andersen J, Mann M, Knippers R and Gruss C: The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. Genes Dev 14: 1308-1312, 2000. (Pubitemid 30397074)
6. Waldmann T, Eckerich C, Baack M and Gruss C: The ubiquitous chromatin protein DE K alters the structure of DNA by introducing positive supercoils. J Biol Chem 277: 24988-24994, 2002.
7. Hollenbach AD, McPherson CJ, Mientjes EJ, Iyengar R and Grosveld G: Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein DEK. J Cell Sci 115: 3319-3300, 2002.
8. Carro MS, Spiga FM, Quarto M, Di Ninni V, Volorio S, Alcalay M and Muller H: DEK expression is controlled by E2F and deregulated in diverse tumor types. Cell Cycle 5: 1202-1207, 2006. (Pubitemid 43845381)
9. Kim DW, Chae JI, Kim JY, Pak JH, Koo DB, Bahk YY and Seo SB: Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK. J Cell Biochem 106: 1048-1059, 2009.
10. Manevich Y, Sweitzer T, Pak JH, Feinstein SI, Muzykantov V and Fisher AB: 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc Natl Acad Sci 99: 11599-11604, 2002.
11. Hatada EN, Krappmann D and Scheidereit C: NF-kappaB and the innate immune response. Curr Opin Immunol 12: 52-58, 2000.
12. Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-kappaB activity. Annu Rev Immunol 18: 621-663, 2000.
13. Sammons M, Wan SS, Vogel NLNL, Mientjes EJ, Grosveld G and Ashburner BP: Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene. J Biol Chem 281: 26802-26812, 2006.
14. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA and Mayo MW: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J 23: 2369-2380, 2004. (Pubitemid 38954844)
15. Shaw J, Zhang T, Rzeszutek M, Yurkova N, Baetz D, Davie JR and Kirshenbaum LA: Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes. Circ Res 99: 1347-1354, 2006. (Pubitemid 44949670)